XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 52,931 $ 47,322 $ 34,157
Reconciliation of net income to net cash provided by operating activities:      
Depreciation and amortization 22,240 28,669 23,383
Stock-based compensation 3,835 4,711 3,987
Accretion of discount on Series B Debentures 85 106 134
Impairment of right of use asset 1,439 351
Capital loss (gain) from sale of property and equipment 26 (60) 44
Net changes in operating assets and liabilities      
Increase in net trade receivables, unbilled receivables and contract assets (21,860) (13,937) (5,168)
Decrease (increase) in other operating assets 7,729 17,743 (2,049)
Decrease in deferred tax liabilities, net (10,134) (1,902) (16)
Increase (decrease) in trade payables 4,634 (529) (1,344)
Decrease (increase) in other operating liabilities (8,046) (8,325) 1,435
Increase (decrease) deferred revenues (7,738) 4,930 2,992
Increase in accrued severance pay, net 78 375 349
Net cash provided by operating activities 43,780 80,542 58,255
Cash flows from investing activities:      
Purchase of property and equipment (2,757) (3,786) (2,633)
Proceeds from sale of property and equipment 54 1,111 12
Capitalized software development costs (6,097) (7,911) (5,798)
Net cash received from (paid for) acquisitions (b) (3,466) 831 (109,052)
Proceeds from (investment in) short-term bank deposits, net 26 10,031 (30,397)
Proceeds from restricted deposit on account of future acquisition 22,890
Purchase of other intangible asset (200) (151) (2,810)
Net cash provided by )used in( investing activities (12,440) 125 (127,788)
Cash flows from financing activities:      
Proceeds from employee stock options exercised 2,038 5,050
Receipt of short-term loan 20,000
Repayment of loans (20,000)
Proceeds from issuance of Series B Debentures, net of issuance expenses 60,346
Repayment of Series B Debentures (19,796) (19,796) (9,898)
Distribution of dividend (38,579) (20,255) (7,044)
Payments of contingent consideration (926) (538)
Acquisition of non-controlling interests (990) (147)
Dividend to non-controlling interest (31)
Proceeds from issuance of ordinary shares, net of issuance expenses 108,737
Net cash provided by (used in) financing activities (58,375) (39,960) 156,506
Effect of exchange rate changes on cash (2,923) (3,025) (707)
Increase (decrease) in cash, and cash equivalents (29,958) 37,682 86,266
Cash, cash equivalents at beginning of year 190,243 152,561 66,295
Cash and cash equivalents at end of year 160,285 190,243 152,561
Supplemental cash flow activities:      
Interest, net 850 3,218 5,439
Income taxes, net 10,634 6,654 16,330
Fair value of assets acquired and liabilities assumed at the date of acquisition:      
Working capital, net (excluding cash and cash equivalents) 317 238 10,839
Other long-term assets (9,577)
Other long-term liabilities 24,572
Redeemable non-controlling interests 450
Goodwill and other intangible assets (3,783) 593 (135,336)
Net cash paid for acquisitions, total (3,466) 831 (109,052)
(c) Non-cash transactions:      
Net lease liabilities arising (modifying) from obtaining right-of-use assets (24) 5,526 1,861
Property and equipment purchase incurred but unpaid at year end $ 268 $ 262 $ 490